We are live on ! Find out more
TECX

Tectonic Therapeutic

54 hedge funds and large institutions have $15.7M invested in Tectonic Therapeutic in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 18 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.29% less ownership

Funds ownership: 4.94%4.65% (-0.29%)

16% less funds holding

Funds holding: 6454 (-10)

34% less capital invested

Capital invested by funds: $23.8M → $15.7M (-$8.17M)

44% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 18

63% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 16

Holders
54
Holders Change
-10
Holders Change %
-15.63%
% of All Funds
0.93%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
10
Reduced
18
Closed
16
Calls
Puts
Net Calls
Net Calls Change

TECX Hedge Fund Activity: Q3 2022 in Review

54 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Tectonic Therapeutic (TECX) for Q3 2022, worth a combined $15.7M — down 34% from $23.8M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of TECX and 6 opened new positions — a net loss of 10 holders — while 18 trimmed existing stakes and 10 added.

The largest buyer was K2 Principal Fund, adding an estimated $1.5M. The largest seller was JP Morgan Chase, cutting an estimated $1.9M.

  • 54 institutional investors held Tectonic Therapeutic (TECX) as of Q3 2022, down from 64 in Q2 2022.
  • Funds reported $15.7M of Tectonic Therapeutic stock for Q3 2022, down 34% quarter-over-quarter.
  • 6 funds opened new Tectonic Therapeutic positions in Q3 2022 and 16 closed out, a net change of -10 holders.
  • The largest Tectonic Therapeutic buyer in Q3 2022 was K2 Principal Fund, an estimated $1.5M added.
  • The largest Tectonic Therapeutic seller in Q3 2022 was JP Morgan Chase, an estimated $1.9M sold.

Based on aggregated 13F filings for Q3 2022.